In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).
efficacious therapy for Type 2 diabetes with the majority of data indicating improved A1c and fasting plasma glucose and decreased side-effect profile compared with standard GLP1-RA preparations.
Evan Y. Yu, MD, discusses the design and objectives of the phase 3 PEACE 3 study, which evaluates the combination of enzalutamide (ENZA) and radium-223 (Ra-223) in androgen receptor pathway inhibitor ...
Bone metastases are at the center of advanced prostate cancer care, with over 90% of patients with metastatic prostate cancer expected to have bone involvement. 1 These metastatic ...
Film wasn’t the only thing on people’s minds at this year’s Sundance Film Festival, which comes to a close Sunday in Park City, Utah. The effects of the wildfires in ...